Kelly L. Stratton, MD

Associate Professor
Department of Urology, Stephenson Cancer Center, University of Oklahoma

Kelly Stratton, M.D., FACS is an Associate Professor of Urologic Oncology in the Department of Urology and serves as an Adjunct Associate Professor of Medical Oncology at the Stephenson Cancer Center at the University of Oklahoma Health Sciences Center Campus. He completed his Urology residency at Vanderbilt University Medical Center and continued on to complete a Urologic Oncology Fellowship at Memorial Sloan Kettering cancer Center. As a surgeon he provides expertise in the operative management of urologic malignancies. He is the Clinic Director of the Prostate and Urologic Cancer Clinic where multi-disciplinary management of complex cancers are provided using protocol driven and clinical trial based care models. Dr. Stratton serves as the Chair of the Stephenson Cancer Center Data Safety Monitoring Board, Disease Site Chair for Urologic Cancers and as a member of the Oklahoma TSET Phase I Clinical Trials Program, and is the Director of research for the Department of Urology. His clinical research interests include advanced imaging of localized prostate cancer and new techniques for diagnosing prostate cancer.

Disclosure information not submitted.

Presentation(s):

• Second Opinion Cases: Focal Therapy for Prostate Cancer: Should it Replace Standard of Care?

  Friday, May 13, 2022
  7:30 AM – 7:50 AM

• Focal therapy for moderate and high-risk prostate cancer

  Friday, May 13, 2022
  1:50 PM – 2:10 PM

• 046IC - Integrating Care for Oncology Patients: Establishing a Multidisciplinary Oncology Clinic with Advanced Therapeutics

  Saturday, May 14, 2022
  4:00 PM – 6:00 PM

• Panel Discussion: Challenging Cases in Prostate Cancer Screening

  Sunday, May 15, 2022
  8:45 AM – 9:15 AM